World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ChiCTR
Last refreshed on: 18 April 2017
Main ID:  ChiCTR-OOC-15006038
Date of registration: 2015-03-04
Prospective Registration: Yes
Primary sponsor: Peking Union Medical College Hospital
Public title: Retrospective study on association between vaginal microbiota and the histocompatibility of transvaginal pelvic polypropylene mesh
Scientific title: Association between vaginal microbiota and the histocompatibility of transvaginal pelvic polypropylene mesh
Date of first enrolment: 2015-03-06
Target sample size: exposure group:30;non-exposure group:50;
Recruitment status: Recruiting
URL:  http://www.chictr.org.cn/showproj.aspx?proj=10503
Study type:  Observational study
Study design:  Case-Control study  
Phase:  Other
Countries of recruitment
China
Contacts
Name: Zhibo Zhang   
Address:  No.1,Shuaifuyuan,Dongcheng Destrict, Beijing
Telephone: 13693317164
Email: zzbspace@126.com
Affiliation:  Peking Union Medical College Hospital
Name: Lan Zhu   
Address:  No.1,Shuaifuyuan,Dongcheng Destrict, Beijing
Telephone: 13911714696
Email: zhu_julie@vip.sina.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Menopausal POP patients who have already accepted trans-vaginally placed mesh treatment.
Exclusion criteria: 1. Patients with Diabetes and the blood glucose is not controlled under the target level;
2. Patients with immunological diseases and have been taking glucocorticoid hormone or anti-immunolgical drugs regularly;
3. Patients who had taken antibiotics or antifungal disease in latest 30 days;
4. Patients who had sexual life, trans-vaginally placed drug or vaginal lavage in the past 48 hours;
5. Patients who had bacterial vaginosis or sexually transmitted disease at the current visit;
6. Patients who had intrauterine device.


Age minimum:
Age maximum:
Gender: Female
Health Condition(s) or Problem(s) studied
Pelvic organ prolapse
Intervention(s)
exposure group:no intervention;non-exposure group:no intervention;
Primary Outcome(s)
the structure and abundance of vaginal microbiota;
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
Self-collected
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history